Robarts Clinical Trials is a niche GI Contract Research Organization. We have been providing a complete range of clinical research services to a broad base of academic and industry clients since 1986. In 2018, Robarts transitioned ownership from Western University to the Health Academic Research Trust. This new social enterprise structure prioritizes employees, R&D investment and strong fiscal management in support of its mission to transform human health.
We are global. With headquarters in Canada (London, Ontario) and offices in the United States (La Jolla, California) and Europe (Amsterdam, The Netherlands), we are an international and culturally diverse organization.
We are collaborators. Robarts Clinical Trials works with pharmaceutical and biotechnology companies, government agencies, key opinion leaders and the investigator community to advance the development of effective treatments. We work alongside our clients to provide tailored and innovative recommendations for the design and implementation of their research. We work with you from concept to completion.
We are pioneers. Robarts Clinical Trials is committed to developing new solutions to improve clinical trial outcomes and accelerate drug development timelines. We were the first to bring solutions for central imaging of endoscopy and histopathology to the market and have recently built a translational science network which can accelerate and enhance early drug development.
We are evidence-based experts. Our foundation is built on expertise in inflammatory bowel disease (IBD) and other chronic gastrointestinal diseases and clinical trial design. We are recognized as international leaders in outcomes development, cluster randomization trials, and centralized imaging solutions. Our vast R & D and clinical research experience forms the basis for our integrated solutions to complex operational needs and regulatory standards.